Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Zollinger-Ellison Syndrome 1Stomach Ulcer 1Neoplasms 1Neoplasm Metastasis 1Esophagitis, Peptic 1Barrett Esophagus 1

Interventions

Esomeprazole 3Radiofrequency Ablation 2Endoscopy, Digestive System 2rofecoxib 1YF 476 1X-Rays 1Narrow Band Imaging 1Lansoprazole 1Endoscopy 1Diagnostic Imaging 1Dexlansoprazole 1Cryosurgery 1Blood Specimen Collection 1Biopsy 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Barrett Esophagus × Lansoprazole × Clear all
NCT00352261 2009-03-26

An Open Label pH Comparison of Esomeprazole and Lansoprazole in Barrett's Esophagus Patients

AstraZeneca

Phase 4 Completed
80 enrolled
Gastrointestinal

Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡